RS 102895,
RS 102895 hydrochloride,
300815-41-2,
RS-102895 Hydrochloride,
1173022-16-6,
RS 102895,
RS102895 hydrochloride,
RS102895 (hydrochloride),
1'-(4-(Trifluoromethyl)phenethyl)spiro[benzo[d][1,3]oxazine-4,4'-piperidin]-2(1H)-one hydrochloride,
AK160379,
1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-spiro[4h-3,1-benzoxazine-4,4'-piperidin]-2(1h)-one hydrochloride,
C21H21F3N2O2.ClH,
SCHEMBL3719729,
CHEMBL1317124,
CTK8F0373,
AOB5546,
DTXSID50587871,
BCP18408,
4017AH,
BS0168,
MFCD08703093,
AKOS024456940,
ACN-052277,
API0008334,
CS-3486,
NCGC00092306-01,
HY-18611,
RT-015454,
4CH-020863,
ST24036535,
KS-00000006,
J-017767,
RS 102895 hydrochloride, >=98% (HPLC), powder,
1 inverted exclamation marka-[2-[4-(Trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4 inverted exclamation marka-peperidin]-2(1H)-one,
1'-[2-[4-(Trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one HCl,
1'-[2-[4-(Trifluoromethyl)phenyl]ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one hydrochloride,
1'-{2-[4-(Trifluoromethyl)phenyl]ethyl}spiro[3,1-benzoxazine-4,4'-piperidin]-2(1H)-one--hydrogen chloride (1/1),
1-[2-[4-(Trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4-piperidin]-2(1H)-one hydrochloride,
Spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one, 1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-, hydrochloride (1:1),
KRRISOFSWVKYBF-UHFFFAOYSA-N,
RS102895,
C573791,